Skip to content
Our Work
About
News & Stories
Contact
Grants
Resources
Careers
Follow us on Facebook
Follow us on Twitter
Follow us on Instagram
Follow us on LinkedIn
Search
Open Menu
Resources
Focus Area
All
All
Criminal Justice
Evidence and Evaluation
Health
Higher Education
Public Finance
Research
Topic
Drug Prices
All
Bail Reform
Civica Rx
Climate and Clean Energy
Commercial Sector Prices
Community Safety
Community Supervision
Complex Care
Contraceptive Choice and Access
Data in Higher Education
Drug Prices
Effective Student Success Practices
Federal Tax Policy
Fines and Fees
Fiscal Sustainability
Gun Policy Research
Higher Education Quality and Accountability
Journalism
K-12
Medicare Sustainability
Organ Donation
Police Accountability
Police Response
Policing
Policy Labs
Pretrial Justice
Prisons
Program Integrity
Prosecution
Provider Payment Incentives
Public Defense
Reintegration
Retirement Policy
Same Service, Same Price
The Opioid Epidemic
Violence Reduction
Arnold Ventures Letter on Gene Therapy | Feb.
1
,
2024
Document
Arnold Ventures Comments on
FDA
Substantial Evidence Guidance | Dec.
18
,
2023
Document
Arnold Ventures
IRA
Excise Tax Comment Letter | Dec.
13
,
2023
Document
AV
PEPAXTO
Withdrawal Comment Letter | Sept.
25
,
2023
Document
Arnold Ventures Comments on Medicare Part D Smoothing | Sept.
20
,
2023
Document
AV
Inflation Reduction Act Negotiation Data Elements | July
31
,
2023
Document
AV
Decentralized Clinical Trials Letter | Aug.
1
,
2023
Document
AV
Medicaid Drug Rebate Program comment letter | July
25
,
2023
Document
Pharmacy Benefit Manager Policy Brief
Document
Arnold Ventures Comments on
FDA
Accelerated Approval Draft Guidance
Document
Arnold Ventures Comments on Medicare Drug Price Negotiation Program Guidance
Document
AV
Inflation Penalty Comment Letter | March
10
,
2023
Document
AV
Policy Brief: Medicare Prescription Drug Coverage
Document
Arnold Ventures Drug Pricing Fact Sheet
Document
Arnold Ventures Biosimilar Policy Brief
Document
Arnold Ventures Medicaid Health Policy Brief
Document
Arnold Ventures Real World Evidence (
RWE
) Issue Brief
Document
Arnold Ventures Antimicrobial Resistance (
AMR
) Issue Brief
Document
AV
Working Group
FDASLA
Letter
Document
AV
Letter to
FTC
on PBMs and Drug Affordability
Document
Arnold Ventures Accelerated Approval Issue Brief
Document
Arnold Ventures Health Care
Document
AV
Policy Focus: Drug Pricing
Document
Arnold Ventures Medicaid
VBP
Comment Letter
Document
Prev
1
2
Next
Top
Close Search
What are you looking for?
Search
Submit
Close Menu
Our Work
About
News & Stories
Contact
Grants
Resources
Careers
Press Releases
Employees
Newsletter
Search
Submit
X
Have an evidence-based week
Get The Abstract from Arnold Ventures delivered to your inbox.
Email:
Email Address
This site is protected by reCAPTCHA and the Google
Privacy Policy
and
Terms of Service
apply.